{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T22:08:04Z","timestamp":1785449284813,"version":"3.56.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,2,5]],"date-time":"2018-02-05T00:00:00Z","timestamp":1517788800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s00392-018-1210-x","type":"journal-article","created":{"date-parts":[[2018,2,5]],"date-time":"2018-02-05T12:58:14Z","timestamp":1517835494000},"page":"487-497","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["The contribution of comorbidities to mortality in hospitalized patients with heart failure"],"prefix":"10.1007","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1721-502X","authenticated-orcid":false,"given":"Oliver","family":"Riedel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Ohlmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Enders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Els\u00e4sser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Vizcaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Eberhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Schlothauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Garbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,5]]},"reference":[{"key":"1210_CR1","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/nrcardio.2010.165","volume":"8","author":"AL Bui","year":"2011","unstructured":"Bui AL, Horwich TB, Fonarow GC (2011) Epidemiology and risk profile of heart failure. Nat Rev Cardiol 8:30\u201341","journal-title":"Nat Rev Cardiol"},{"key":"1210_CR2","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1093\/eurjhf\/hft064","volume":"15","author":"R Zarrinkoub","year":"2013","unstructured":"Zarrinkoub R, Wettermark B, Wandell P et al (2013) The epidemiology of heart failure, based on data for 2.1 million inhabitants in Sweden. Eur J Heart Fail 15:995\u20131002","journal-title":"Eur J Heart Fail"},{"key":"1210_CR3","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s00392-017-1137-7","volume":"106","author":"S Stork","year":"2017","unstructured":"Stork S, Handrock R, Jacob J et al (2017) Epidemiology of heart failure in Germany: a retrospective database study. Clin Res Cardiol 106:913\u2013922","journal-title":"Clin Res Cardiol"},{"key":"1210_CR4","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1007\/s00392-017-1138-6","volume":"106","author":"S Stork","year":"2017","unstructured":"Stork S, Handrock R, Jacob J et al (2017) Treatment of chronic heart failure in Germany: a retrospective database study. Clin Res Cardiol 106:923\u2013932","journal-title":"Clin Res Cardiol"},{"key":"1210_CR5","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1093\/eurheartj\/eht066","volume":"34","author":"FP Brouwers","year":"2013","unstructured":"Brouwers FP, de Boer RA, van der Harst P et al (2013) Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND. Eur Heart J 2013 34:1424\u20131431","journal-title":"Eur Heart J"},{"key":"1210_CR6","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1023\/A:1009884820941","volume":"5","author":"W Kannel","year":"2000","unstructured":"Kannel W (2000) Incidence and epidemiology of heart failure. Heart Fail Rev 5:167\u2013173","journal-title":"Heart Fail Rev"},{"key":"1210_CR7","doi-asserted-by":"crossref","first-page":"163","DOI":"10.47102\/annals-acadmedsg.V39N3p163","volume":"39","author":"GKM Lee","year":"2010","unstructured":"Lee GKM, Lee LC, Liu CWY et al (2010) Framingham risk score inadequately predicts cardiac risk in young patients presenting with a first myocardial infarction. Ann Acad Med Singap 39:163\u2013167","journal-title":"Ann Acad Med Singap"},{"key":"1210_CR8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1093\/eurjhf\/hfq121","volume":"13","author":"CSP Lam","year":"2011","unstructured":"Lam CSP, Donal E, Kraigher-Krainer E, Vasan RS (2011) Epidemiology and clinical course of heart failure with preserved ejection fraction. Eur J Heart Fail 13:18\u201328","journal-title":"Eur J Heart Fail"},{"key":"1210_CR9","doi-asserted-by":"crossref","unstructured":"in patients with heart failure with preserved ejection fraction stratified by study design: a systematic review. Eur J Heart Fail 18: 54\u201365","DOI":"10.1002\/ejhf.442"},{"key":"1210_CR10","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1056\/NEJMoa052256","volume":"355","author":"TE Owan","year":"2006","unstructured":"Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM (2006) Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 355:251\u2013259","journal-title":"N Engl J Med"},{"key":"1210_CR11","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.jacc.2009.06.067","volume":"55","author":"WJ Paulus","year":"2010","unstructured":"Paulus WJ, van Ballegoij JJM (2010) Treatment of heart failure with normal ejection fraction an inconvenient truth! J Am Coll Cardiol 55:526\u2013537","journal-title":"J Am Coll Cardiol"},{"key":"1210_CR12","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1093\/eurjhf\/hfp103","volume":"11","author":"JB Somaratne","year":"2009","unstructured":"Somaratne JB, Berry C, McMurray JJV, Poppe KK, Doughty RN, Whalley GA (2009) The prognostic significance of heart failure with preserved left ventricular ejection fraction: a literature-based meta-analysis. Eur J Heart Fail 11:855\u2013862","journal-title":"Eur J Heart Fail"},{"key":"1210_CR13","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.jacc.2007.04.064","volume":"50","author":"GC Fonarow","year":"2007","unstructured":"Fonarow GC, Stough WG, Abraham WT et al (2007) Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure\u2014a report from the OPTIMIZE-HF registry. J Am Coll Cardiol 50:768\u2013777","journal-title":"J Am Coll Cardiol"},{"key":"1210_CR14","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jacc.2005.09.022","volume":"47","author":"CW Yancy","year":"2006","unstructured":"Yancy CW, Lopatin M, Stevenson LW et al (2006) Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function\u2014a report from the Acute Decompensated Heart Failure National Registry (ADHERE) database. J Am Coll Cardiol 47:76\u201384","journal-title":"J Am Coll Cardiol"},{"key":"1210_CR15","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ejheart.2005.01.008","volume":"7","author":"U Dahlstrom","year":"2005","unstructured":"Dahlstrom U (2005) Frequent non-cardiac comorbidities in patients with chronic heart failure. Eur J Heart Fail 7:309\u2013316","journal-title":"Eur J Heart Fail"},{"key":"1210_CR16","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.ejheart.2006.01.010","volume":"8","author":"FH Rutten","year":"2006","unstructured":"Rutten FH, Cramer MJM, Lammers JWJ, Grobbee DE, Hoes AW (2006) Heart failure and chronic obstructive pulmonary disease: An ignored combination? Eur J Heart Fail 8:706\u2013711","journal-title":"Eur J Heart Fail"},{"key":"1210_CR17","doi-asserted-by":"publisher","first-page":"430-U380","DOI":"10.1016\/j.ahj.2011.12.013","volume":"163","author":"EM Hsich","year":"2012","unstructured":"Hsich EM, Grau-Sepulveda MV, Hernandez AF et al (2012) Sex differences in in-hospital mortality in acute decompensated heart failure with reduced and preserved ejection fraction. Am Heart J 163:430-U380","journal-title":"Am Heart J"},{"key":"1210_CR18","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1001\/archinte.161.15.1849","volume":"161","author":"W Jiang","year":"2001","unstructured":"Jiang W, Alexander J, Christopher E et al (2001) Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med 161:1849\u20131856","journal-title":"Arch Intern Med"},{"key":"1210_CR19","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","volume":"62","author":"WJ Paulus","year":"2013","unstructured":"Paulus WJ, Tschope C (2013) A novel paradigm for heart failure with preserved ejection fraction comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol 62:263\u2013271","journal-title":"J Am Coll Cardiol"},{"key":"1210_CR20","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1056\/NEJMoa032566","volume":"350","author":"MR Zile","year":"2004","unstructured":"Zile MR, Baicu CF, Gaasch WH (2004) Diastolic heart failure\u2014abnormalities in active relaxation and passive stiffness of the left ventricle. New Engl J Med 350:1953\u20131959","journal-title":"New Engl J Med"},{"key":"1210_CR21","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1161\/CIRCULATIONAHA.110.011031","volume":"124","author":"MR Zile","year":"2011","unstructured":"Zile MR, Gottdiener JS, Hetzel SJ et al (2011) Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction. Circulation 124:2491\u20132501","journal-title":"Circulation"},{"key":"1210_CR22","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1056\/NEJMoa0805450","volume":"359","author":"BM Massie","year":"2008","unstructured":"Massie BM, Carson PE, McMurray JJ et al (2008) Irbesartan in patients with heart failure and preserved ejection fraction. New Engl J Med 359:2456\u20132467","journal-title":"New Engl J Med"},{"key":"1210_CR23","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/eurheartj\/ehv464","volume":"37","author":"SD Solomon","year":"2016","unstructured":"Solomon SD, Claggett B, Lewis EF et al (2016) Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction. Eur Heart J 37:455\u2013462","journal-title":"Eur Heart J"},{"key":"1210_CR24","unstructured":"Parsons L (2001) Reducing bias in a propensity score matched-pair sample using greedy matching techniques. SUGI26. Paper 214\u201326"},{"key":"1210_CR25","unstructured":"Chiang C (1967) Standard error of the age-adjusted death rate. Vital Statistics\u2014Special Reports, Selected Studies 47"},{"key":"1210_CR26","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1016\/j.jacc.2014.08.036","volume":"64","author":"RJ Mentz","year":"2014","unstructured":"Mentz RJ, Kelly JP, von Lueder TG et al (2014) Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction. J Am Coll Cardiol 64:2281\u20132293","journal-title":"J Am Coll Cardiol"},{"key":"1210_CR27","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.jacc.2003.07.046","volume":"43","author":"K Hogg","year":"2004","unstructured":"Hogg K, Swedberg K, McMurray J (2004) Heart failure with preserved left ventricular systolic function: epidemiology, clinical characteristics, and prognosis. J Am Coll Cardiol 43:317\u2013327","journal-title":"J Am Coll Cardiol"},{"key":"1210_CR28","volume-title":"Chronic conditions among medicare benificiaries\u2014Chartboo, 2012 Edition","author":"Centres for Medicare & Medicaid Services","year":"2012","unstructured":"Centres for Medicare & Medicaid Services (2012) Chronic conditions among medicare benificiaries\u2014Chartboo, 2012 Edition. Centes for Medicare & Medicaid Services, Baltimore"},{"key":"1210_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00392-017-1170-6","volume":"107","author":"C Tschope","year":"2018","unstructured":"Tschope C, Birner C, Bohm M et al (2018) Heart failure with preserved ejection fraction: current management and future strategies. Clin Res Cardiol 107:1\u201319","journal-title":"Clin Res Cardiol"},{"key":"1210_CR30","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/ejhf.30","volume":"16","author":"VM Deursen van","year":"2014","unstructured":"van Deursen VM, Urso R, Laroche C et al (2014) Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot Survey. Eur J Heart Fail 16:103\u2013111","journal-title":"Eur J Heart Fail"},{"key":"1210_CR31","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.ijcard.2016.06.080","volume":"220","author":"A Ruigomez","year":"2016","unstructured":"Ruigomez A, Michel A, Martin-Perez M, Rodriguez LAG (2016) Heart failure hospitalization: an important prognostic factor for heart failure re-admission and mortality. Int J Cardiol 220:855\u2013861","journal-title":"Int J Cardiol"},{"key":"1210_CR32","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.jacc.2011.11.040","volume":"59","author":"S Ather","year":"2012","unstructured":"Ather S, Chan W, Bozkurt B et al (2012) Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction. J Am Coll Cardiol 59:998\u20131005","journal-title":"J Am Coll Cardiol"},{"key":"1210_CR33","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.ahj.2005.03.056","volume":"151","author":"GM Felker","year":"2006","unstructured":"Felker GM, Shaw LK, Stough WG, O\u2019Connor CM (2006) Anemia in patients with heart failure and preserved systolic function. Am Heart J 151:457\u2013462","journal-title":"Am Heart J"},{"key":"1210_CR34","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1093\/eurheartj\/ehn153","volume":"29","author":"MR MacDonald","year":"2008","unstructured":"MacDonald MR, Petrie MC, Varyani F et al (2008) Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure. Eur Heart J 29:1377\u20131385","journal-title":"Eur Heart J"},{"key":"1210_CR35","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1161\/CIRCOUTCOMES.113.000221","volume":"6","author":"DH Smith","year":"2013","unstructured":"Smith DH, Thorp ML, Gurwitz JH et al (2013) Chronic kidney disease and outcomes in heart failure with preserved versus reduced ejection fraction the cardiovascular research network PRESERVE study. Circ Cardiovasc Qual Outcomes 6:333\u2013342","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"1210_CR36","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1002\/ejhf.824","volume":"19","author":"J Lupon","year":"2017","unstructured":"Lupon J, Diez-Lopez C, de Antonio M et al (2017) Recovered heart failure with reduced ejection fraction and outcomes: a prospective study. Eur J Heart Fail 19:1615\u20131623","journal-title":"Eur J Heart Fail"},{"key":"1210_CR37","doi-asserted-by":"crossref","unstructured":"Chang HJ, Chen PC, Yang CC, Su YC, Lee CC (2016) Comparison of Elixhauser and Charlson methods for predicting oral cancer survival. Medicine 95","DOI":"10.1097\/MD.0000000000002861"},{"key":"1210_CR38","doi-asserted-by":"crossref","unstructured":"Li B, Evans D, Faris P, Dean S, Quan H (2008) Risk adjustment performance of Charlson and Elixhauser comorbidities in ICD-9 and ICD-10 administrative databases. BMC Health Serv Res 8","DOI":"10.1186\/1472-6963-8-12"},{"key":"1210_CR39","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1097\/MLR.0b013e31825f64d0","volume":"50","author":"MTA Sharabiani","year":"2012","unstructured":"Sharabiani MTA, Aylin P, Bottle A (2012) Systematic review of comorbidity indices for administrative data. Med Care 50:1109\u20131118","journal-title":"Med Care"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00392-018-1210-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-018-1210-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-018-1210-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T21:22:53Z","timestamp":1693516973000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00392-018-1210-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,5]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["1210"],"URL":"https:\/\/doi.org\/10.1007\/s00392-018-1210-x","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,5]]},"assertion":[{"value":"3 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"A Michel and D Vizcaya are full-time employees of Bayer AG. J. Berg is a full-time employee of the statutory health insurance AOK Bremen\/Bremerhaven. S. Eberhard is full-time employee of the statutory health insurance AOK Niedersachsen. O. Riedel, D. Enders, N. Schlothauer, A. Els\u00e4sser and C. Ohlmeier have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}